Synapse Open Synapse
News

FDA warns of rare eye condition causing blindness from GLP-1 weight loss medications

The Guardian World · · 2 min read

The federal agency is requiring all GLP-1s to include information about the potential risk on warning labels The US Food and Drug Administration (FDA) has issued a new warning on GLP-1 medications – which can facilitate weight loss – over a rare eye condition that could lead to sudden and permanent blindness .

Latest from The Guardian World